mortality/aging
|
• animals start to die at 4.5 months, with >50% mortality observed at 7 months
(J:125114)
• 50% mortality by 20 weeks; <40% survival beyond 40 weeks
(J:137066)
|
hematopoietic system
|
• significantly enhanced at 12 and 16 weeks
|
|
• rolling is dramatically reduced, but not eliminated, in mutants compared to controls
• in mice chronically treated with anti-E-selectin antibodies, rolling is completely eliminated
|
|
• severe
|
|
• 46% of venules display leukocytes adjacent to endothelium, compared to only 145 in controls; in mutants and controls, 60-70% of these cells are mononuclear
|
|
• significantly increased relative to controls
|
|
• reduced compared to wild-type MRL animals
|
|
• reduced compared to wild-type MRL animals
|
|
• mice develop hypergammaglobulinemia
|
immune system
|
• mice develop systemic necrotizing arteritis of small- and medium-sized arteries; frequently observed in kidneys
|
|
• significantly enhanced at 12 and 16 weeks
|
|
• rolling is dramatically reduced, but not eliminated, in mutants compared to controls
• in mice chronically treated with anti-E-selectin antibodies, rolling is completely eliminated
|
|
• severe
|
|
• 46% of venules display leukocytes adjacent to endothelium, compared to only 145 in controls; in mutants and controls, 60-70% of these cells are mononuclear
|
|
• significantly increased relative to controls
|
|
• reduced compared to wild-type MRL animals
|
|
• reduced compared to wild-type MRL animals
|
|
• mice develop hypergammaglobulinemia
|
|
• severe
|
|
• mice develop anti-nuclear antibodies (ie. anti-dsDNA, anti-ssDNA, etc)
|
|
• IgG3 anti-IgG2a rheumatoid factor (RF) levels are much higher than wild-type controls
|
|
• levels of anti-dsDNA and anti-chromatin autoantibodies are elevated compared to wild-type
|
|
• mice show deposition of IgG or C3 in kidneys and inflammation
(J:125114)
|
cardiovascular system
|
• mice develop systemic necrotizing arteritis of small- and medium-sized arteries; frequently observed in kidneys
|
renal/urinary system
|
• mice show deposition of IgG or C3 in kidneys and inflammation
(J:125114)
|
cellular
|
• significantly enhanced at 12 and 16 weeks
|
|
• rolling is dramatically reduced, but not eliminated, in mutants compared to controls
• in mice chronically treated with anti-E-selectin antibodies, rolling is completely eliminated
|
growth/size/body
|
• severe
|


Analysis Tools